| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,438 |
5,184 |
$529K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,844 |
2,728 |
$217K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,077 |
5,059 |
$192K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,763 |
1,763 |
$163K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,340 |
1,340 |
$122K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,218 |
1,200 |
$106K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,626 |
3,611 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
211 |
208 |
$18K |
| 96127 |
|
3,012 |
2,510 |
$12K |
| 99188 |
|
1,129 |
1,129 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
206 |
200 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
67 |
67 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
446 |
432 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
158 |
157 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
110 |
109 |
$3K |
| 99215 |
Prolong outpt/office vis |
17 |
15 |
$3K |
| 87634 |
|
32 |
32 |
$2K |
| 0071A |
|
48 |
48 |
$2K |
| 0072A |
|
39 |
39 |
$2K |
| 54150 |
|
12 |
12 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
16 |
16 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$537.94 |
| 96161 |
|
77 |
76 |
$385.00 |
| 99051 |
|
28 |
28 |
$184.20 |
| 90656 |
|
177 |
177 |
$31.00 |
| 90686 |
|
1,107 |
1,107 |
$6.00 |
| 96160 |
|
1,405 |
1,401 |
$0.00 |
| 90671 |
|
93 |
93 |
$0.00 |
| 99072 |
|
1,852 |
1,704 |
$0.00 |
| 90670 |
|
282 |
282 |
$0.00 |
| 90648 |
|
409 |
409 |
$0.00 |
| 90681 |
|
12 |
12 |
$0.00 |
| G9920 |
Screening performed and negative |
25 |
25 |
$0.00 |
| 90707 |
|
12 |
12 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,249 |
1,712 |
$0.00 |
| 90723 |
|
131 |
131 |
$0.00 |
| 91307 |
|
103 |
102 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |